# Pramipexole

## Mirapex 0.375mg prolonged-release

| TAH Drug Code      | [OMIRA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OMIRA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of signs & symptoms of Parkinson's disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | Parkinson's disease: start from 0.375 mg given once per day. Based on efficacy and tolerability, dosages may be increased gradually, not more frequently than every 5 to 7 days, first to 0.75 mg per day and then by 0.75 mg increments up to a maximum recommended dose of 4.5 mg per day. When discontinuing therapy, taper the dose gradually over a period of one week. In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), start from 0.375 mg given every other day. Dose adjustment should occur no more frequently than at weekly intervals. Maximum: 2.25 mg/day.                                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Hypersensitivity. Lactation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Adverse Effects    | Abnormal behaviors (eg, binge eating, compulsive shopping, hypersexuality, pathological gambling), abnormal dreams, amnesia, cardiac failure, confusion, constipation, delusion, dizziness, dyskinesia, dyspnoea, fatigue, hallucinations, headache, hiccups, hyperkinesia, hyperphagia, hypotension, inappropriate antidiuretic hormone secretion, insomnia, libido disorders, nausea, paranoia, peripheral oedema; pneumonia; pruritus, rash; restlessness, somnolence, sudden onset of sleep, syncope, visual impairment including diplopia, blurred vision, reduced visual acuity; vomiting, decreased appetite, increased/decreased wt. |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| More Info          | [UpToDate](https://www.uptodate.com/contents/pramipexole-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

